Wednesday, February 10, 2010, 8:59am EST - Canadian Markets open in 31 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Insmed Incorporated (INSM)

 On Feb 9: 0.81 USD   0.00 (0.00%)  
MORE ON INSM
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Insmed, Inc. (NCM:INSM) Delayed quote dataEdit
Last Trade: 0.81 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 0.81
Open: N/A
Bid: 0.79 x 9000
Ask: 0.83 x 9500
1y Target Est: 2.00
Day's Range: N/A - N/A
52wk Range: 0.41 - 2.57
Volume: 0
Avg Vol (3m): 615,205
Market Cap: 105.47M
P/E (ttm): N/A
EPS (ttm): -0.35
Div & Yield: N/A (N/A%)
Insmed Incorporated (INSM)
1d  5d  3m  6m  1y  2y  5y  max 
 Add INSM to Portfolio   Download Data

HEADLINES
• Under the Radar Developments at Insmed
at Seeking Alpha (Sun, Jan 31)
• The Schloss Screen for 2010
RealMoney by TheStreet.com (Wed, Jan 6)
• Old School Value Stock Portfolio Performance 2009
at Seeking Alpha (Tue, Jan 5)
• Buy a Company, Get the Plant for Free
at Motley Fool (Fri, Dec 18)
• 8 Cheap Stocks Trading Below Net Net Working Capital
at Seeking Alpha (Mon, Dec 14)
• 4 More Stocks on Wall Street's Dollar Menu
at Motley Fool (Mon, Dec 7)
• INSMED INC Financials
EDGAR Online Financials (Fri, Nov 13)
• INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Fri, Nov 6)
• Insmed Incorporated Earnings Call scheduled for 8:30 am ET today
CCBN (Fri, Nov 6)
• Sirius Breaks the Buck
at Motley Fool (Fri, Sep 18)
• INSMED INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf
EDGAR Online (Wed, Sep 16)
• INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Aug 13)
• 5 More Stocks on Wall Street's Dollar Menu
at Motley Fool (Wed, Aug 12)
More Headlines for INSM...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 2.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Insmed Incorporated, a biopharmaceutical company, engages in the development and commercialization of drugs to treat metabolic diseases, endocrine disorders, and oncology.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices